PBH
Prestige Consumer Healthcare Inc
Price:  
61.22 
USD
Volume:  
275,238.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PBH Relative Valuation

86.0%
Upside

As of 2026-01-05, the Relative Valuation of Prestige Consumer Healthcare Inc (PBH) is 113.84 USD. This relative valuation is based on P/E multiples. With the latest stock price at 61.22 USD, the upside of Prestige Consumer Healthcare Inc based on Relative Valuation is 86.0%.

The range of the Relative Valuation is 80.45 - 158.84 USD.

Range Selected
Trailing P/E multiples 19.3x - 30.5x 26.2x
Forward P/E multiples 21.9x - 36.1x 27.0x
Fair Price 80.45 - 158.84 113.84
Upside 31.4% - 159.5% 86.0%
61.22 USD
Stock Price
113.84 USD
Fair Price

PBH Relative Valuation - Historical P/E Data

Date P/E
2025-12-31 14.77
2025-12-30 14.90
2025-12-29 15.25
2025-12-26 15.04
2025-12-24 14.94
2025-12-23 14.92
2025-12-22 15.01
2025-12-19 14.78
2025-12-18 14.83
2025-12-17 14.92
2025-12-16 14.75
2025-12-15 14.81
2025-12-12 14.71
2025-12-11 14.57
2025-12-10 14.69
2025-12-09 14.35
2025-12-08 14.44
2025-12-05 14.56
2025-12-04 14.38
2025-12-03 14.43
2025-12-02 14.29
2025-12-01 14.35
2025-11-28 14.26
2025-11-26 14.26
2025-11-25 14.13
2025-11-24 13.76
2025-11-21 14.23
2025-11-20 14.17
2025-11-19 14.00
2025-11-18 14.17
2025-11-17 14.12
2025-11-14 14.37
2025-11-13 14.36
2025-11-12 14.49
2025-11-11 14.50
2025-11-10 14.47
2025-11-07 14.35
2025-11-06 14.69
2025-11-05 14.32
2025-11-04 14.49
2025-11-03 14.50
2025-10-31 14.51
2025-10-30 14.43
2025-10-29 14.53
2025-10-28 14.85
2025-10-27 14.94
2025-10-24 14.90
2025-10-23 14.98
2025-10-22 15.17
2025-10-21 14.96